Aminocaproic Acid (Hospira, Inc.)
Welcome to the PulseAid listing for the Aminocaproic Acid drug offered from Hospira, Inc.. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | AMINOCAPROIC ACID |
| SUBSTANCE NAME: | AMINOCAPROIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-05-12 |
| END MARKETING DATE: | 0000-00-00 |
Aminocaproic Acid HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aminocaproic Acid from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/mL) |
| START MARKETING DATE: | 2010-05-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0409-4346_379e13e8-8775-4b06-bbf9-1473b7cb7cfd |
| PRODUCT NDC: | 0409-4346 |
| APPLICATION NUMBER: | ANDA070010 |
Other AMINOCAPROIC ACID Pharmaceutical Manufacturers / Labelers:
